Diabetes and fasting during the SARS-COV 2 pandemic

Khaoula Ben Ali; Eya Safi; Berriche Olfa; Olfa Lajili; Sliman Chayma Bel Hadj; Oueslati Insaf; Hajer Moalla; Othman Rym Ben; Faten Mahjoub; Jamoussi Henda

doi:10.1530/endoabs.90.EP507

EP507

Prev Next

Section Contents Cite

Endocrine Abstracts (2023) 90 EP507 | DOI: 10.1530/endoabs.90.EP507

ECE2023 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (355 abstracts)

Diabetes and fasting during the SARS-COV 2 pandemic

Ben Ali Khaoula , Eya Safi , Berriche Olfa , Olfa Lajili , Bel Hadj Sliman Chayma , Oueslati Insaf , Hajer Moalla , Rym Ben Othman , Faten Mahjoub & Jamoussi Henda

Err

Author affiliations

National Institute of Nutrition, Service A of Diabetology and Nutrition, Tunis, Tunisia.

Introduction: The covid-19 pandemic has affected the diabetic population and their glycemic control, in particular Muslim diabetics fasting during the month of Ramadan. Our objective was to assess the glycemic control between Ramadan 2020 (April) and Ramadan 2021 (April) and to determine the impact of the pandemic on the Fasting authorization.

Methods: This is a prospective study including 30 diabetic patients followed at department A, at the National Institute of Nutrition in Tunis. Each patient underwent a clinical examination and a blood test.

Results: The mean age was 59.53+11.16 years. The mean diabetes duration was 9.7±6.9 years. The majority of patients were type 2 diabetics (93%). More than a quarter were on insulin (27%) (n=8). Only three patients (10%) had a SARS-cov2 infection. Before Ramadan 2020, the mean fasting Glycemia was 9.47+2.8 mmol/l and the mean HbA1c was 8.25+1.52%. Among our patients, 43% (n=13) had HBA1c in the objectives. Ramadan 2020 fasting was authorized in 43% of patients (those with HBA1c in target) and antidiabetic treatment was appropriate in 90% of cases. The 2020 Ramadan fasting was complicated by hypoglycemia and hyperglycemia in 7% and 13% of cases respectively. only one patient stopped the fasting. Before Ramadan 2021, the mean fasting Glycemia was 10.51+3.2 mmol/l and the mean HBA1C was 8.15+1.6%. Before Ramadan 2021, glycemic target was reached in 48% of patients (n=14), with an improvement of 5%.

Conclusion: The period of the pandemic has influenced the glycemic control in our diabetic population who practice Ramadan fasting. More studies will be needed to further assess this interference.